(Q42926715)

English

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

scientific article published on 5 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

1 reference

based on heuristic

inferred from title

author name string

G Zugmaier

1

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

M S Topp

2

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

S Alekar

3

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

A Viardot

4

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

H-A Horst

5

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

S Neumann

6

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

M Stelljes

7

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

R C Bargou

8

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

M Goebeler

9

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

D Wessiepe

10

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

E Degenhard

11

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

N Gökbuget

12

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

M Klinger

13

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

publication date

5 September 2014

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Blood Cancer Journal

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

4

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

244

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

1 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1038/bcj.2014.64

0 references

B-cell targeted therapeutics in clinical development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

27 May 2018

Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

27 May 2018

Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

27 May 2018

Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

27 May 2018

Does rituximab aggravate pre-existing hypogammaglobulinaemia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

27 May 2018

Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

27 May 2018

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

27 May 2018

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

16 August 2018

Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

16 August 2018

Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

16 August 2018

Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4183773

16 August 2018

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

1 reference

https://api.crossref.org/works/10.1038%2FBCJ.2014.64

21 January 2018

Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25192414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BCJ.2014.64

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42926715&oldid=1973910489"